Articles from HIV Treatment: ALERTS! (April 1, 2005)

1-57 out of 57 article(s)

Title	Author	Type	Words
"Compound X.".		Brief Article	15
Antibiotic side effects.		Brief Article	152
Avoiding complications in HIV.		Brief Article	146
Baylor College of Medicine.		Brief Article	151
BMS 488043.		Brief Article	18
Caution: combination of Viread, Videx, and either Sustiva or Viramune.		Advertisement	74
Dangers of treatment interruption.		Brief Article	92
Deaths in the HIV+ population.			78
Diarrhea dilemmas.		Brief Article	92
Doubts about hydroxyurea.		Brief Article	119
Drugs for GI upset may interact with HIV protease inhibitors.		Brief Article	214
Early viral load predicts treatment success.		Brief Article	143
Erythromycin risks.		Brief Article	198
FDA approves generic version of Videx EC delayed release capsules.		Brief Article	96
Fewer pills for Invirase.		Brief Article	57
First hepatitis C treatment approved for co-infected patients.			61
Fuzeon update.			340
Good news: the effects of HAART.		Brief Article	185
Hepatitis warnings with Epivir.		Advertisement	135
HIV and kidney function.		Brief Article	254
HIV in the brain.			189
HPV update.			377
HSIL in HIV+ girls.		Brief Article	199
Hyperglycemia--another Viread + Videx risk.		Brief Article	105
Hypertension risks.		Brief Article	171
Is an undetectable viral load necessary?		Brief Article	254
Kaletra warning.		Advertisement	296
Lipodystrophy problems continue.		Brief Article	178
Liver failure in co-infected patients.			165
Liver toxicity warning.		Advertisement	85
Lung cancer and HIV.			104
Methadone adjustment with Viramune.		Brief Article	93
New CDC guidelines to prevent HIV.		Brief Article	269
One regimen, one pill, once a day.		Brief Article	85
PA-457.		Brief Article	88
Pancreas problems.			497
Past drug use may affect T cell count.		Brief Article	185
Pregnant women should not use Crixivan.		Brief Article	56
Problems with Kaletra and Dilantin combo.		Brief Article	103
Reyataz heart risks.		Brief Article	60
RNase H Inhibitor.			6
Shingles: still an issue.			303
SMART Study.		Brief Article	249
STD dangers.			360
Stem cell transplants for cancer.			352
Studies in Galveston.			466
Super strain of HIV?			392
Sustiva warnings.		Brief Article	169
The immune system (Part 1 of 2): T cells, B cells, and cytokines.	Williams, Marjorie		719
The price of Fuzeon resistance.		Brief Article	153
The science behind dementia.			248
Tipranavir.			91
TMC 114.		Brief Article	84
Toxoplasmosis: still a threat.			349
Update to HIV treatment guidelines.		Brief Article	274
Useful resources.		Directory	149
Welcome.		Brief Article	219